Found 16 matching trials
Reduced PCV Dosing Schedules in South African Infants PHASE3 This study will evaluate the immunogenicity of a reduced dosing schedule of...
Show More Location
Chris Hani Baragwanath Academic Hospital
Learn More & Join Trial
Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy PHASE2 The study hypothesis is that a "reinforced" pneumococcal combined vaccine s...
Show More Location
Pôle de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques " Hôpital Cochin, Assistance Publique-Hôpitaux de Paris
Learn More & Join Trial
Impact of Vaccines on Antimicrobial Microbial Resistance N/A Vaccination is a potentially critical component of efforts to arrest develo...
Show More Location
Malawi Liverpool Wellcome Programme
Learn More & Join Trial
Phase I Clinical Trial of a Candidate PCV13 in Healthy People PHASE1 Streptococcus pneumoniae is a major cause of morbidity and mortality in chi...
Show More Location
Xiangtan Maternal and Child Health Hospital
Learn More & Join Trial
Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-2) N/A Observational study about adherence to guidelines for Covid-19, Influenza, ...
Show More Location
Ciudad Real General University Hospital
Learn More & Join Trial
Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine PHASE1 This study is an open-label combined randomized double-blind, positive cont...
Show More Location
Henan Center for Diseases Control and Prevention
Learn More & Join Trial
A Phase 3 Study to Evaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13 PHASE3 The goal of this clinical trial is to evaluate the immunogenicity and safet...
Show More Location
RSUP Prof. Dr. I.G.N.G Ngoerah
Learn More & Join Trial
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) PHASE3 Streptococcus pneumoniae is a major cause of morbidity and mortality in chi...
Show More Location
Neihuang Center for Disease Control and Prevention
Learn More & Join Trial
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above PHASE1 Streptococcus pneumoniae is a major cause of morbidity and mortality in chi...
Show More Location
Neihuang Center for Disease Control and Prevention
Learn More & Join Trial
Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso PHASE4 This study aims to evaluate the immunogenicity and reactogenicity of 13-val...
Show More Location
CSPS Accart-Ville
Learn More & Join Trial